SCYNEXIS Stock

SCYNEXIS Debt

The Debt of SCYNEXIS (SCYX) as of Sep 4, 2026 is 13.69 M USD. In the previous year, Debt was 12.16 M USD — a change of 12.58% (higher).

Debt

13.69 MUSD

YoY

12.58%

Last updated:

In 2026, SCYNEXIS's total debt was 13.69 M USD, a 12.58% change from the 12.16 M USD total debt recorded in the previous year.

The SCYNEXIS Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2017
14.70 M USD
Jan 1, 2018
15.10 M USD
Jan 1, 2019
11.50 M USD
Jan 1, 2020
16.50 M USD
Jan 1, 2021
40.40 M USD
Jan 1, 2022
45.40 M USD
Jan 1, 2023
12.16 M USD
Jan 1, 2024
13.69 M USD
The SCYNEXIS Debt history
YEARDebtYoY
13.69 MUSD+12.58%
12.16 MUSD-73.22%
45.40 MUSD+12.38%
40.40 MUSD+144.85%
16.50 MUSD+43.48%
11.50 MUSD-23.84%
15.10 MUSD+2.72%
14.70 MUSD+2.80%
14.30 MUSD—
0.00USD—
0.00USD—
Access this data via the Eulerpool API
Get Free API Key

SCYNEXIS Stock analysis

What does SCYNEXIS do? SCYNEXIS Inc is a biopharmaceutical company that focuses on the discovery and development of novel therapeutics for serious infectious diseases and cancer. The company was founded in 2000 and is headquartered in New Jersey, USA. SCYNEXIS is one of the most popular companies on Eulerpool.

Debt Details

Understanding SCYNEXIS's Debt Structure

SCYNEXIS's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing SCYNEXIS's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to SCYNEXIS’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in SCYNEXIS’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about SCYNEXIS stock

Debt of SCYNEXIS is 13.69 M USD in 2026.

Debt of SCYNEXIS changed from 12.16 M USD to 13.69 M USD, representing a 12.58% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt SCYNEXIS since 2006 – with annual values, charts, and detailed analysis.

Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's SCYNEXIS historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — SCYNEXIS

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — SCYNEXIS